Ed Wass
Portfolio Partner @ Gresham House Ventures
Ed Wass is a venture - series unknown investor at Gresham House Ventures focused on Machine Learning and Artificial Intelligence. Ed Wass is the Portfolio Partner at Gresham House Ventures. Ed attended University of Nottingham.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Ed Wass invests in
Stages Ed Wass invests in
Countries Ed Wass invests in
Investment Focus
Industry
- Machine Learning 2 (40%)
- Artificial Intelligence 2 (40%)
- Retail 1 (20%)
- Scheduling 1 (20%)
- Biotechnology 1 (20%)
Stage
- Venture - Series Unknown 2 (40%)
- Series A 1 (20%)
- Series B 1 (20%)
- Funding Round 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Vivacity Labs
|
Vivacity's goal is to introduce the missing pieces of the digital infrastructure underlying its transport systems. Vivacity is empowering transport managers to take the next step in reducing congestion and improving safety on the roads, through providing unprecedented insight. Vivacity wants to make those transport managers omniscient.Toachieve this, Vivacity is installing thousands of sensors across the UK, including creating the UK's first transport-focused smart city in Milton Keynes, as the first step in this journey to revolutionize the way data is collected. Each sensor uses the same technology being built into driverless vehicles, based on machine learning and artificial intelligence on video feeds, in order to gather a level of data that has never been available before.Using this data, Vivacity is building advanced predictive algorithms to give deep insights into what's going to happen next in the transport system, again using machine learning in order to pre-empt the future. | $8.5M / Venture - Series Unknown / Feb 16, 2023 | |
Rotageek
|
Rotageek helps organisations predict and meet demand, using complex data-driven technologies to effectively and fairly schedule staff. They use personalised algorithms and machine learning to find patterns that would otherwise go unnoticed - providing best in class and fully personalised business forecasting and scheduling. Today, Rotageek livesin London and Melbourne and their clients include O2, Dune, William Hill, Maplin and The Perfume Shop to name just a few. They’re growing really quickly but their approach and their ambitions remain personal, and they always will. Their goal is to create a step change in scheduling capabilities using data-driven, highly intelligent technology that is agile and works both for business and people. | $3.7M / Venture - Series Unknown / Jun 22, 2022 | |
|
Vivacity Labs
|
Vivacity's goal is to introduce the missing pieces of the digital infrastructure underlying its transport systems. Vivacity is empowering transport managers to take the next step in reducing congestion and improving safety on the roads, through providing unprecedented insight. Vivacity wants to make those transport managers omniscient.Toachieve this, Vivacity is installing thousands of sensors across the UK, including creating the UK's first transport-focused smart city in Milton Keynes, as the first step in this journey to revolutionize the way data is collected. Each sensor uses the same technology being built into driverless vehicles, based on machine learning and artificial intelligence on video feeds, in order to gather a level of data that has never been available before.Using this data, Vivacity is building advanced predictive algorithms to give deep insights into what's going to happen next in the transport system, again using machine learning in order to pre-empt the future. | $7M / Series A / Feb 22, 2021 | |
Lumora
|
Lumora Ltd, a Cambridgeshire Business Park, UK-based molecular diagnostics company. The company intends to use the funds to accelerate its entry into the clinical molecular diagnostic market. Based on its proprietary BART Technology platform, Lumora is developing programs focusing on:- an integrated testing station for gastrointestinal (GI)infections, and- an HIV viral load monitoring system to support drug therapy in the developing world. | $917K / Mar 19, 2013 | |
|
Lumora
|
Lumora Ltd, a Cambridgeshire Business Park, UK-based molecular diagnostics company. The company intends to use the funds to accelerate its entry into the clinical molecular diagnostic market. Based on its proprietary BART Technology platform, Lumora is developing programs focusing on:- an integrated testing station for gastrointestinal (GI)infections, and- an HIV viral load monitoring system to support drug therapy in the developing world. | $2M / Series B / May 26, 2011 |
Co-Investors
About Gresham House Ventures
We are growth investors. Our aim is to ensure that every business we are involved with maximises its potential for the benefit of all stakeholders. We back ambitious businesses that compete on strength of technology, customer insight or service excellence. We have deep experience and networks across consumer markets, TMT, service sectors, andhealthcare and education.
Gresham House Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Ed Wass
Portfolio Partner
|
|||
Rowan Grobler
Investment Director
|
|||
Rupesh Patel
Investment Director
|
|||
James Hendry
Associate Director
|
|||
Robert Henry
Portfolio Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ed Wass invest in?
Ed Wass invests primarily in Machine Learning, Artificial Intelligence and Retail startups, most often at Venture - Series Unknown and Series A stage. Most of the 5 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Ed Wass last invest?
The most recent investment recorded for Ed Wass closed in Feb 2023. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
